Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
31.98
+2.60 (8.85%)
Apr 17, 2026, 4:08 PM HKT

HKG:3378 Statistics

Total Valuation

HKG:3378 has a market cap or net worth of HKD 4.36 billion. The enterprise value is 3.75 billion.

Market Cap4.36B
Enterprise Value 3.75B

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date Mar 27, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:3378 has 136.22 million shares outstanding.

Current Share Class 136.22M
Shares Outstanding 136.22M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.43%
Owned by Institutions (%) 2.32%
Float 19.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 235.60
PB Ratio 5.24
P/TBV Ratio 5.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -25.71
EV / Sales 202.71
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.27, with a Debt / Equity ratio of 0.07.

Current Ratio 7.27
Quick Ratio 6.86
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.26

Financial Efficiency

Return on equity (ROE) is -27.27% and return on invested capital (ROIC) is -15.85%.

Return on Equity (ROE) -27.27%
Return on Assets (ROA) -11.38%
Return on Invested Capital (ROIC) -15.85%
Return on Capital Employed (ROCE) -15.57%
Weighted Average Cost of Capital (WACC) 8.95%
Revenue Per Employee 336,190
Profits Per Employee -2.65M
Employee Count 55
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax -15.07M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.84
52-Week Price Change n/a
50-Day Moving Average 22.06
200-Day Moving Average n/a
Relative Strength Index (RSI) 69.83
Average Volume (20 Days) 187,110

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:3378 had revenue of HKD 18.49 million and -145.79 million in losses. Loss per share was -1.24.

Revenue18.49M
Gross Profit 18.49M
Operating Income -145.56M
Pretax Income -161.40M
Net Income -145.79M
EBITDA -143.32M
EBIT -145.56M
Loss Per Share -1.24
Full Income Statement

Balance Sheet

The company has 725.74 million in cash and 62.16 million in debt, with a net cash position of 663.57 million or 4.87 per share.

Cash & Cash Equivalents 725.74M
Total Debt 62.16M
Net Cash 663.57M
Net Cash Per Share 4.87
Equity (Book Value) 831.96M
Book Value Per Share n/a
Working Capital 664.03M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Depreciation & Amortization 2.32M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -787.24%
Pretax Margin -872.87%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HKG:3378 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -3.35%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a